AstraZeneca (AZNCF) News Today $168.24 -0.04 (-0.02%) As of 02:36 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartDividendFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock AZNCF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period AstraZeneca hails EU approval of Tezspire for rhinosinusitis formOctober 22 at 6:34 AM | lse.co.ukDaiichi, AstraZeneca report breast cancer gains with Enhertu, DatrowayOctober 20 at 2:29 AM | lse.co.ukHow the Narrative Around AstraZeneca Is Shifting Amid New Risks and Pipeline DevelopmentsOctober 18, 2025 | finance.yahoo.comFDA Approves Amgen and AstraZeneca Treatment for Nasal Polyps ConditionOctober 17, 2025 | marketwatch.comAstraZeneca expands Coppell manufacturing site, adding about 30 skilled jobsOctober 16, 2025 | msn.comJP Morgan Cazenove Reiterates AstraZeneca (AZNCF) Overweight RecommendationOctober 15, 2025 | msn.comTrump Strikes Deal With AstraZeneca To Slash U.S. Drug PricesOctober 13, 2025 | yahoo.comAstraZeneca inks Trump drug pricing deal amid tariff threatsOctober 13, 2025 | finance.yahoo.comAstraZeneca agrees to lower drug prices for Medicaid under Trump administration dealOctober 12, 2025 | msn.comTrump announces deal with pharma giant AstraZeneca to lower drug pricesOctober 12, 2025 | msn.comTrump, AstraZeneca Unveil Partnership Aimed At Reducing Drug Prices In The USOctober 11, 2025 | msn.comTrump announces deal with AstraZeneca aimed at lowering drug pricesOctober 11, 2025 | yahoo.comTrump to announce drug-price deal with AstraZenecaOctober 10, 2025 | msn.comTrump, AstraZeneca unveil drug pricing breaks for US consumersOctober 10, 2025 | yahoo.comTrump unveils deal for AstraZeneca to cut Medicaid drug prices and join "TrumpRx" siteOctober 10, 2025 | msn.comAstraZeneca becomes latest drugmaker to strike deal with Trump. Its stock is climbing after hours.October 10, 2025 | msn.comTrump to announce deal with AstraZeneca to lower drug costsOctober 10, 2025 | msn.comTrump, AstraZeneca announce US drug pricing deal at White HouseOctober 10, 2025 | yahoo.comAstraZeneca ups investment in Virginia; Moderna vets launch VC fundOctober 10, 2025 | finance.yahoo.comTurbine and AstraZeneca partner for ADC discoveryOctober 10, 2025 | yahoo.comAstraZeneca Lifts US Plant Investment to $4.5 Billion to Boost Drug ManufacturingOctober 10, 2025 | uk.finance.yahoo.comShore Capital Reiterates AstraZeneca (AZNCF) Buy RecommendationOctober 8, 2025 | msn.comAstraZeneca Shares Surge 14% as Investment Pause Spurs Fresh Valuation DebateOctober 8, 2025 | finance.yahoo.comAstraZeneca’s New York shift augurs London exodusOctober 7, 2025 | reuters.comAstraZeneca touts positive results in trial for hypertension therapyOctober 7, 2025 | lse.co.ukAstraZeneca’s experimental hypertension drug shows promising resultsOctober 7, 2025 | za.investing.comAstraZeneca signs up to $555 million AI deal with Algen to develop therapiesOctober 7, 2025 | msn.comAlgen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZenecaOctober 6, 2025 | finance.yahoo.comAstraZeneca, Daiichi drug boosts survival in aggressive breast cancerOctober 6, 2025 | lse.co.ukAstraZeneca PLC: Datroway improved OS and PFS in TROPION-Breast02October 6, 2025 | finanznachrichten.deAstraZeneca’s Datroway shows survival benefit in metastatic breast cancerOctober 6, 2025 | investing.comAstraZeneca and Daiichi's Datroway boosts overall survival in breast cancer trialOctober 6, 2025 | yahoo.comAstraZeneca signs $555mn AI deal to develop gene-editing therapiesOctober 6, 2025 | ft.comHow Recent Developments Are Shaping the Story and Outlook for AstraZenecaOctober 4, 2025 | finance.yahoo.comAstraZeneca’s US listing to leave £200mn UK stamp duty holeOctober 2, 2025 | ft.comAstraZeneca (AZN) Jumps to All-Time High on Trump Drug Tariff DelayOctober 2, 2025 | msn.comStock Movers: AstraZeneca, Puma, GreggsOctober 1, 2025 | bloomberg.comAstraZeneca climbs Wednesday, outperforms marketOctober 1, 2025 | marketwatch.comAnalysis-AstraZeneca's US listing may pull other firms from London in its wakeSeptember 30, 2025 | finance.yahoo.comAstraZeneca Plans Full US Listing While Defusing Fears of UK ExitSeptember 30, 2025 | money.usnews.comAstraZeneca plans direct US listingSeptember 30, 2025 | finance.yahoo.comAstraZeneca stokes fears of London exit with New York listingSeptember 29, 2025 | finance.yahoo.comAstraZeneca plans overhaul of US listing to attract more investorsSeptember 29, 2025 | ft.comAstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technologySeptember 26, 2025 | reuters.comAstraZeneca launches DTC platform amid US pricing pressuresSeptember 26, 2025 | finance.yahoo.comAstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditionsSeptember 26, 2025 | finance.yahoo.comAstraZeneca asks Supreme Court to hear lawsuit challenging Medicare drug price negotiationSeptember 25, 2025 | msn.comSet to go up 57%? Here are the latest share price forecasts for AstraZenecaSeptember 25, 2025 | uk.finance.yahoo.comAstraZeneca and Daiichi's breast cancer drug wins US priority reviewSeptember 24, 2025 | lse.co.ukAstraZeneca Wins European Committee's Positive Opinion for Two Drugs Tackling Chronic, Rare DiseasesSeptember 22, 2025 | uk.finance.yahoo.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AZNCF Media Mentions By Week AZNCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZNCF News Sentiment▼0.180.52▲Average Medical News Sentiment AZNCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZNCF Articles This Week▼47▲AZNCF Articles Average Week Get the Latest News and Ratings for AZNCF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AstraZeneca and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 4Front Ventures News Today Ainos News Today Algernon Pharmaceuticals News Today AVAX Technologies News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AZNCF) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts